Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jason B. Douglas"'
Autor:
Jason B Douglas, Swetha Chenna, Venu Madhav Chippa, Matthew R Fulton, Amr Moussa, Amy R Hurst
Publikováno v:
Archives of Hematology Case Reports and Reviews. :004-006
Rivaroxaban was approved for stroke prevention for non-valvular atrial fibrillation in 2011, with added advantage of decreased risk of bleeding in comparison to coumadin, made it a good alternative for coumadin.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23b9683e8cc0de8906d181b0c9712e5e
https://doi.org/10.17352/ahcrr.000012
https://doi.org/10.17352/ahcrr.000012
Autor:
Barry I. Graubard, Michael Pollak, Yuzhen Tao, Stephanie J. Weinstein, Debra T. Silverman, Demetrius Albanes, Rachael Z. Stolzenberg-Solomon, Jarmo Virtamo, Jason B. Douglas
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 20:359-369
Background: Many epidemiologic studies have examined the association between C-reactive protein (CRP) and risk of cancer with inconsistent results. Methods: We conducted two nested, case–control studies in the Alpha-Tocopherol, Beta-Carotene Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c13d40ee42be9fab2d05713f3e2c946b
https://doi.org/10.1158/1055-9965.epi-10-1024
https://doi.org/10.1158/1055-9965.epi-10-1024
Autor:
Yuzhen Tao, Michael Pollak, Debra T. Silverman, Rachael Z. Stolzenberg-Solomon, Amr S. Soliman, Jason B. Douglas
Background: Experimental evidence suggests that an overexpression of insulin-like growth factor (IGF)-I is implicated in human pancreatic tumors. Increased IGF-II and decreased IGF binding protein (IGFBP)-3 serum concentrations have been linked to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70ef6a0a9ab1a18f63985094d0dd0e15
https://europepmc.org/articles/PMC2936681/
https://europepmc.org/articles/PMC2936681/
Autor:
Yuzhen Tao, Michael Pollak, Rachael Z. Stolzenberg-Solomon, Jason B. Douglas, Amr S. Soliman, Debra T. Silverman
Publikováno v:
Cancer Research. 70:2795-2795
Experimental evidence suggests that an overexpression of insulin-like growth factor-I (IGF-I) is implicated in human pancreatic tumors. Moreover, increased IGF-II and decreased insulin-like growth factor binding protein-3 (IGFBP-3) concentrations are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7eea3da9cf835967c6440621554dab9
https://doi.org/10.1158/1538-7445.am10-2795
https://doi.org/10.1158/1538-7445.am10-2795